Biography
Teaching is a top priority for Dr. Streett who feels that mentoring fellows in the development of their careers is a privilege. She has held many national leadership roles in the American Gastroenterological Association, where she has been Chair of the Practice Management and Economics Committee, and currently serves on the Government Affairs Committee. She also an appointed member of the Gastrointestinal Drug Advisory Committee at the FDA. She has represented the interests of gastroenterologists and their patients on Capitol Hill numerous times. Dr. Streett believes strongly in a collaborative approach to give patients personalized care based on the latest therapies for the treatment of IBD and is committed to mentoring the next generation of experts in the field.
Professional Summary
Education & Certifications
- Board Certification: American Board of Internal Medicine, Gastroenterology (2012)
- Fellowship: Stanford School of Medicine (1997)
- Residency: Stanford School of Medicine (1994)
-
- Internship: Stanford School of Medicine (1992)
- Medical Education: Johns Hopkins University School of Medicine (1991) MD
Honors & Awards
- Champion of Hope, Crohn's and Colitis Foundation (2018)
- Fellow, American Gastroenterology Association (AGAF), American Gastroenterology Association (2017)
-
Memberships
- Member, Gastrointestinal Drugs Advisory Committee (2020 - Present)
- Member, Leadership Council, AGA (2016 - 2017)
- Committee Chairperson, Practice Management and Economics, AGA (2015 - 2018)
-
Administrative Appointments
- Clinical Professor, Stanford University (2021 - Present)
- Director, IBD Education, Stanford University (2019 - Present)
- Member, Gastrointestinal Drugs Advisory Committee, FDA (2020 - Present)
-
- Member, Government Affairs Committee, American Gastroenterology Association (2018 - Present)
Publications
-
Does gender affect career satisfaction and advancement in gastroenterology? Results of an AGA institute-sponsored survey
Gerson, L. B., Twomey, K., Hecht, G., Lee, L., McQuaid, K., Pizarro, T. T., … Early, D. (2007). Does gender affect career satisfaction and advancement in gastroenterology? Results of an AGA institute-sponsored survey. GASTROENTEROLOGY, 132(4), 1598–1606. -
Endoscopic colorectal cancer screening in women: can we do better?
Streett, S. E. (2007). Endoscopic colorectal cancer screening in women: can we do better? GASTROINTESTINAL ENDOSCOPY, 65(7), 1047–1049. -
Our Practices, Ourselves: How do we establish a Personal Connection with our Patients
Streett, S. E. (2010). Our Practices, Ourselves: How do we establish a Personal Connection with our Patients. AGA Perspectives, 6(4). -
-
White Paper AGA: An Episode-of-Care Framework for the Management of Obesity: Moving Towards High Value, High Quality Care: A Report from the American Gastroenterological Association Institute Obesity Episode of Care and Bundle Initiative Work Group.
Brill, J. V., Ashmore, J. A., Brengman, M. L., Buffington, D. E., Feldshon, S. D., Friedman, K. E., … Streett, S. E. (2017). White Paper AGA: An Episode-of-Care Framework for the Management of Obesity: Moving Towards High Value, High Quality Care: A Report from the American Gastroenterological Association Institute Obesity Episode of Care and Bundle Initiative Work Group. Clinical Gastroenterology and Hepatology . -
White Paper AGA: POWER - Practice Guide on Obesity and Weight Management, Education and Resources.
Acosta, A., Streett, S., Kroh, M. D., Cheskin, L. J., Saunders, K. H., Kurian, M., … Aronne, L. (2017). White Paper AGA: POWER - Practice Guide on Obesity and Weight Management, Education and Resources. Clinical Gastroenterology and Hepatology . -
American Society of Clinical Oncology Summit on Addressing Obesity Through Multidisciplinary Provider Collaboration: Key Findings and Recommendations for Action.
Ligibel, J. A., Alfano, C. M., Hershman, D. L., Merrill, J. K., Basen-Engquist, K., Bloomgarden, Z. T., … Hudis, C. A. (2017). American Society of Clinical Oncology Summit on Addressing Obesity Through Multidisciplinary Provider Collaboration: Key Findings and Recommendations for Action. Obesity (Silver Spring, Md.), 25 Suppl 2, S34–S39. -
Mass cytometry reveals systemic and local immune signatures that distinguish inflammatory bowel diseases.
Rubin, S. J., Bai, L., Haileselassie, Y., Garay, G., Yun, C., Becker, L., … Habtezion, A. (2019). Mass cytometry reveals systemic and local immune signatures that distinguish inflammatory bowel diseases. Nature Communications, 10(1), 2686. -
A Failure to Communicate: Disentangling the Causes of Perianal Fistula in Crohn's Disease and Anal Squamous Cell Cancer.
Weingarden, A. R., Smith, P., Streett, S., & Triadafilopoulos, G. (2020). A Failure to Communicate: Disentangling the Causes of Perianal Fistula in Crohn's Disease and Anal Squamous Cell Cancer. Digestive Diseases and Sciences. -
Biologics for Inflammatory Bowel Disease and their Safety in Pregnancy: A Systematic Review and Meta-analysis.
Nielsen, O. H., Gubatan, J. M., Juhl, C. B., Streett, S. E., & Maxwell, C. (2020). Biologics for Inflammatory Bowel Disease and their Safety in Pregnancy: A Systematic Review and Meta-analysis. Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association. -
Biologics During Pregnancy in Women With Inflammatory Bowel Disease and Risk of Infantile Infections: A Systematic Review and Meta-Analysis.
Gubatan, J., Nielsen, O. H., Levitte, S., Juhl, C. B., Maxwell, C., Streett, S. E., & Habtezion, A. (2020). Biologics During Pregnancy in Women With Inflammatory Bowel Disease and Risk of Infantile Infections: A Systematic Review and Meta-Analysis. The American Journal of Gastroenterology. -
Development of AGA's Policy Agenda During the COVID-19 Pandemic.
Mathews, S. C., Natarajan, Y., Sofia, M. A., Patel, A., Francis, D., Streett, S., & Siddique, S. M. (2021). Development of AGA's Policy Agenda During the COVID-19 Pandemic. Gastroenterology, 161(3), 765–769. -
Patients Report Infrequent Counseling by Physicians and Inadequate Knowledge about Inflammatory Bowel Disease and Reproductive Health Issues.
Rao, A. K., Zikos, T. A., Garay, G., Lee, K.-E., & Streett, S. E. (1800). Patients Report Infrequent Counseling by Physicians and Inadequate Knowledge about Inflammatory Bowel Disease and Reproductive Health Issues. American Journal of Perinatology. -
Paternal Biologic and Thiopurine Exposure in Inflammatory Bowel Disease and Association With Adverse Pregnancy Outcomes and Semen Parameters: A Systematic Review and Meta-Analysis
Gubatan, J., Barber, G., Nielsen, O. H., Juhl, C., Maxwell, C., Eisenberg, M., & Streett, S. (2021). Paternal Biologic and Thiopurine Exposure in Inflammatory Bowel Disease and Association With Adverse Pregnancy Outcomes and Semen Parameters: A Systematic Review and Meta-Analysis. AMERICAN JOURNAL OF GASTROENTEROLOGY. LIPPINCOTT WILLIAMS & WILKINS. -
Balsalazide Exposure During the Development of Fertilizing Sperm May Be Associated With Offspring Birth Defects.
Wensink, M. J., Streett, S. E., Damkier, P., Lindahl-Jacobsen, R., Kjeldsen, J., & Eisenberg, M. L. (2022). Balsalazide Exposure During the Development of Fertilizing Sperm May Be Associated With Offspring Birth Defects. Inflammatory Bowel Diseases. -
Paternal Medications in Inflammatory Bowel Disease and Male Fertility and Reproductive Outcomes: A Systematic Review and Meta-Analysis.
Gubatan, J., Barber, G. E., Nielsen, O. H., Juhl, C. B., Maxwell, C., Eisenberg, M. L., & Streett, S. E. (2022). Paternal Medications in Inflammatory Bowel Disease and Male Fertility and Reproductive Outcomes: A Systematic Review and Meta-Analysis. Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association. -
A tissue atlas of ulcerative colitis revealing evidence of sex-dependent differences in disease-driving inflammatory cell types and resistance to TNF inhibitor therapy.
Mayer, A. T., Holman, D. R., Sood, A., Tandon, U., Bhate, S. S., Bodapati, S., … Rogalla, S. (2023). A tissue atlas of ulcerative colitis revealing evidence of sex-dependent differences in disease-driving inflammatory cell types and resistance to TNF inhibitor therapy. Science Advances, 9(3), eadd1166. -
A tissue atlas of ulcerative colitis revealing evidence of sex-dependent differences in disease-driving inflammatory cell types and resistance to TNF inhibitor therapy
Mayer, A. T., Holman, D. R., Sood, A., Tandon, U., Bhate, S. S., Bodapati, S., … Rogalla, S. (2023). A tissue atlas of ulcerative colitis revealing evidence of sex-dependent differences in disease-driving inflammatory cell types and resistance to TNF inhibitor therapy. SCIENCE ADVANCES, 9(3). -
Gastroenterology Clinic Follow-Up Reduces Gastroenterology-Specific Readmissions Among Patients With Severe Ulcerative Colitis.
Barber, G. E., Zhuo, J., Okafor, P. N., & Streett, S. (2023). Gastroenterology Clinic Follow-Up Reduces Gastroenterology-Specific Readmissions Among Patients With Severe Ulcerative Colitis. Inflammatory Bowel Diseases. -
White Paper: American Gastroenterological Association Position Statement: The Future of IBD Care in the United States - Removing Barriers and Embracing Opportunities.
Sofia, M. A., Feuerstein, J. D., Narramore, L., Chachu, K. A., & Streett, S. (2024). White Paper: American Gastroenterological Association Position Statement: The Future of IBD Care in the United States - Removing Barriers and Embracing Opportunities. Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association. -
Updates on the management of inflammatory bowel disease from periconception to pregnancy and lactation.
Nielsen, O. H., Gubatan, J. M., Kolho, K.-L. L., Streett, S. E., & Maxwell, C. (2024). Updates on the management of inflammatory bowel disease from periconception to pregnancy and lactation. Lancet (London, England).
-
White Paper AGA: An Episode-of-Care Framework for the Management of Obesity: Moving Towards High Value, High Quality Care: A Report from the American Gastroenterological Association Institute Obesity Episode of Care and Bundle Initiative Work Group.
Clinical Trials
Clinical trials are research studies that evaluate a new medical approach, device, drug, or other treatment. As a Stanford Health Care patient, you may have access to the latest, advanced clinical trials.
Open trials refer to studies currently accepting participants. Closed trials are not currently enrolling, but may open in the future.
- Study To Evaluate The Efficacy And Safety Of Oral PF-06651600 And PF-06700841 In Subjects With Moderate To Severe Crohn's Disease
- Study to Assess Efficacy and Safety of Cx601, Adult Allogeneic Expanded Adipose-derived Stem Cells (eASC) for the Treatment of Complex Perianal Fistula(s) in Participants With Crohn's Disease (CD)
Practice Locations
Inflammatory Bowel Disease (IBD) Program Redwood City, CA
Redwood City, CAInflammatory Bowel Disease (IBD) Program
420 Broadway Street, Pavilion D, 2nd Floor
Redwood City , CA 94063
Make An Appointment More Clinic Information Getting HereDigestive Health Center in Redwood City Redwood City, CA
Redwood City, CADigestive Health Center in Redwood City
420 Broadway Street, Pavilion D 2nd Floor
Redwood City , CA 94063
Make An Appointment More Clinic Information Getting HereGeneral Endoscopy Redwood City, CA
Redwood City, CAGeneral Endoscopy
420 Broadway St, Pavilion D 2nd Fl
Redwood City , CA 94063
Make An Appointment More Clinic Information Getting HereImportant Information about Our Organizations and Physician Affiliation
Stanford Health Care, Stanford Health Care Tri-Valley, and Stanford Medicine Partners are each independent nonprofit organizations that are affiliated with but separate from each other and from Stanford University. The physicians who provide care at facilities operated by Stanford Health Care, Stanford Health Care Tri-Valley, and Stanford Medicine Partners are faculty, foundation, or community physicians who are not employees, representatives, or agents of Stanford Health Care, Stanford Health Care Tri- Valley, or Stanford Medicine Partners. Stanford Health Care, Stanford Health Care Tri-Valley, and Stanford Medicine Partners do not exercise control over the care provided by such faculty, foundation, and community physicians and are not responsible for their actions.
Patient Reviews
(153 reviews)
View More Patient Reviews
Referring Physicians
PHYSICIAN HELPLINE
Fax: 650-320-9443
Monday–Friday, 8 a.m.–5 p.m.
Stanford Health Care provides comprehensive services to refer and track patients, as well as the latest information and news for physicians and office staff. For help with all referral needs and questions, visit Referral Information.
You may also submit a web referral or complete a referral form and fax it to 650-320-9443 or email the Referral Center at ReferralCenter@stanfordhealthcare.org.
- Send referrals online
- Place radiology and lab orders
- View referral status
- Access medical records